The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)
Open accessAbstract
Background and Purpose —Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) improves the outcome for ischemic stroke patients who can be treated within 3 hours of symptom onset. The efficacy of thrombolysis has been demonstrated despite an increased risk of severe hemorrhagic transformation (HT) in patients treated with rtPA. We performed an analysis of risk factors for severe HT in the second European-Australasian Acute Stroke Study (ECASS II). Methods —HTs were classified by using clinical and radiological criteria as follows: hemorrhagic infarction (HI), parenchymal hemorrhage (PH), and symptomatic intracranial hemorrhage (SICH). Potential risk factors for HT were tested by stepwise logistic regression analysis, including rtPA-by-variable interactions. In addition, the distribution of bad outcome (modified Rankin score 5 to 6) at day 90 was stratified according to each category of HT. Results —PH and SICH but not HI were associated with rtPA. Also, PH and SICH but not HI were more severe in rtPA-treated patients than in those receiving placebo. Risk factors for PH were rtPA, extent of parenchymal hypoattenuation on baseline CT, congestive heart failure, increasing age, and baseline systolic blood pressure. The risk of PH on rtPA was increased in older patients and in those who were treated with aspirin before thrombolysis. Risk factors for SICH were rtPA, congestive heart failure, extent of parenchymal hypoattenuation, and increasing age. The risk of SICH on rtPA was increased in patients who were treated with aspirin before thrombolysis. Conclusions —This secondary analysis of ECASS II has confirmed the importance of the extent of hypoattenuation as a risk factor for severe HT. The findings also suggest that older patients and those who have used aspirin before stroke are at higher risk of a severe HT on rtPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Self-citationFiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Self-citationAdams, H. P., Brott, T. G., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Kwiatkowski, T., Lyden, P. D., Marler, J. R., Torner, J., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1167 · Cited by 730
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Self-citationObservations on brain embolism with special reference to the mechanism of hemorrhagic infarction.
Adams, R. D. (1950) · PubMed · Cited by 322
Primer on Cerebrovascular Diseases
(1997) · Elsevier eBooks · doi:10.1016/b978-0-12-743170-3.x5000-6 · Cited by 253
Gurwitz, J. H., Gore, J. M., Goldberg, R. J., Barron, H. V., Breen, T., Rundle, A. C., Sloan, M. A., French, W., & Rogers, W. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00002 · Cited by 233
Levy, D. E., Brott, T. G., Haley, E. C., Marler, J. R., Sheppard, G. L., Barsan, W., & Broderick, J. P. (1994) · Stroke · doi:10.1161/01.str.25.2.291 · Cited by 211
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease
Stefanadis, C., & TOUTOUZAS, P. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91066-2 · Cited by 142
Ventricular thrombi and thromboembolism in dilated cardiomyopathy: A prospective follow-up study
Falk, R. H., Foster, E., & Coats, M. H. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90757-m · Cited by 126
Lodder, J., Kubat, B., & Broekman, J. (1986) · Stroke · doi:10.1161/01.str.17.4.626 · Cited by 126
Epidemiology and Risk Factor Management
Wolf, P. A. (1997) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-012743170-3.50185-0 · Cited by 12
Cited by
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Self-citationThrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
Demaerschalk, B. M., Kleindorfer, D. O., Adeoye, O. M., Demchuk, A. M., Fugate, J. E., Grotta, J. C., Khalessi, A. A., Levy, E. I., Palesch, Y. Y., Prabhakaran, S., et al. (2016) · Stroke · doi:10.1161/str.0000000000000086 · Cited by 670
Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study
Wahlgren, N., Ahmed, N., Dávalos, A., Hacke, W., Millán, M., Muir, K., Roine, R. O., Toni, D., & Lees, K. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61339-2 · Cited by 569
Metadata
- Authors
- Larrue, V., von Kummer, R., Müller, A., & Bluhmki, E.
- Venue
- Stroke
- Published
- 2001-02
- Volume
- 32
- Issue
- 2
- Pages
- 438-441
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2132357532
- Cited by
- 1,006
- References
- 16
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.